OLD-TAVR score to predict 2-year mortality in patients aged 75 years and more undergoing transcatheter aortic valve replacement

[1] Yamamoto M(2014)Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry Ann Thorac Surg 97 29-36

[2] Mouillet G(2021)Clinical outcomes of transcatheter aortic valve implantation (TAVI) in nonagenarians from the optimized catheter valvular intervention Catheter Cardiovasc Interv 111 1520-1528

[3] Meguro K(2021) TAVI registry Ann Thorac Surg 75 524-745

[4] Gilard M(2022)Longitudinal outcomes of nonagenarians undergoing transcatheter aortic valve replacement Rev Esp Cardiol Engl Ed 41 734-42

[5] Laskar M(2012)2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur J Cardiothorac Surg 88 S23-242

[6] Eltchaninoff H(2009)EuroSCORE II Ann Thorac Surg 115 234-32

[7] Noguchi M(2015)The society of thoracic surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery Am J Cardiol 317 25-376

[8] Tabata M(2020)Value of the “TAVI2-SCORe” versus surgical risk scores for prediction of one year mortality in 511 patients who underwent transcatheter aortic valve implantation Int J Cardiol 110 368-1470

[9] Obunai K(2021)External validation of existing prediction models of 30-day mortality after Transcatheter Aortic Valve Implantation (TAVI) in the Netherlands Heart Registration Clin Res Cardiol 29 1463-1983

[10] Shibayama K(2008)Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients Eur Heart J 34 1976-496

[1] Yamamoto M(2014)Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry Ann Thorac Surg 97 29-36

[2] Mouillet G(2021)Clinical outcomes of transcatheter aortic valve implantation (TAVI) in nonagenarians from the optimized catheter valvular intervention Catheter Cardiovasc Interv 111 1520-1528

[3] Meguro K(2021) TAVI registry Ann Thorac Surg 75 524-745

[4] Gilard M(2022)Longitudinal outcomes of nonagenarians undergoing transcatheter aortic valve replacement Rev Esp Cardiol Engl Ed 41 734-42

[5] Laskar M(2012)2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur J Cardiothorac Surg 88 S23-242

[6] Eltchaninoff H(2009)EuroSCORE II Ann Thorac Surg 115 234-32

[7] Noguchi M(2015)The society of thoracic surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery Am J Cardiol 317 25-376

[8] Tabata M(2020)Value of the “TAVI2-SCORe” versus surgical risk scores for prediction of one year mortality in 511 patients who underwent transcatheter aortic valve implantation Int J Cardiol 110 368-1470

[9] Obunai K(2021)External validation of existing prediction models of 30-day mortality after Transcatheter Aortic Valve Implantation (TAVI) in the Netherlands Heart Registration Clin Res Cardiol 29 1463-1983

[10] Shibayama K(2008)Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients Eur Heart J 34 1976-496